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Normalization of Coronary Flow Reserve by 
Percutaneous Transluminal Coronary Angioplasty 
FELIX ZIJLSTRA, MD, JOHAN C. REIBER, PhD, YVES JUILLIERE, MD, 
and PATRICK W. SERRUYS, MD 
Fifteen patients undergoing routine follow-up angiog- 
raphy 5 months after successful percutaneous 
translumtnal coronary angioplasty (PTCA) wtthout 
angina and with normal exercise thallium scinttgra- 
phy were selected for analysts. The coronary flow 
reserves of these patients were compared with 
those of 24 patients with angiographkally normal 
coronary arteries to establish whether PTCA can re- 
store to normal the coronary flow reserve of pa- 
tknts with chronic coronary artery disease. The 
quantitattve cineangiographk changes and the con- 
comitant alterations in coronary flow reserve as an 
immediate result of the PTCA and the subsequent 
changes 5 months later are described. Coronary 
S ince the introduction of percutaneous transluminal 
coronary angioplasty (PTCA) in 1977,l this procedure 
has gained increasing importance in the treatment of 
coronary artery obstructions. The immediate and,long- 
term results of PTCA are usually assessed by coronary 
angiography. Recently, the measurement of coronary 
flow reserve has been proposed as a better method of 
evaluating the hemodynamic repercussions of coro- 
nary artery obstructions. 2~3 Three techniques have 
been developed that allow the measurement of region- 
al coronary flow reserve during cardiac catheteriza- 
tion. The first uses a pulsed Doppler coronary artery 
catheter that can measure intracoronary blood flow 
velocity.4 The second technique is based on the radio- 
graphic assessment of myocardial perfusion using con- 
trast medium.5,6 The third technique is an indica- 
tor dilution technique with a platinum-tipped PTCA 
guidewire, using hydrogen as the indicator.’ Although 
PTCA has been shown to result in symptomatic, hemo- 
dynamic and functional improvement,8-10 doubt has 
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flow reserve was measured with digital subtraction 
cineangkgraphy. PICA resutted in an increase in 
minimal obstruction area (mean f standard devi- 
ation) from 0.8 f 0.3 to 3.4 -+ 0.7 mm* and in cor- 
onary flow reserve from 1.0 f 0.3 to 2.5 f 0.6. 
Five months later a further substantial and signtft- 
cant (p <0.05) late increase in obstructkm area 
(3.8 f 0.9 mm*) and flow reserve (3.6 f 0.5) had 
occurred. In 11 of 15 patients coronary flow reserve 
was restored to normal. Changes in stenosis geom- 
etry are likely to be 1 of the major determinants of 
this late normalization of coronary flow reserve. 
(Am J Cardtot 1988;61:55-60) 
remained whether this procedure can restore coronary 
flow reserve of atherosclerotic coronary arteries to a 
normal levelll-14 Therefore, we selected 15 patients 
who were free of angina and had a normal exercise 
thallium scintigram 5 months after PTCA and com- 
pared their radiographically measured coronary flow 
reserve with the flow reserve of 24 patients with angio- 
graphically normal coronary arteries. We describe the 
quantitative cineangiographic changes and the con- 
comitant alterations in coronary flow reserve resulting 
from the acute intervention as well as the subsequent 
changes as observed 5 months after PTCA. 
Methods 
Patients: The study population consisted of 24 pa- 
tients with angiographically normal coronary arteries 
[data on 12 have been previously published)5 and 15 
patients with l-vessel coronary artery disease. These 
15 patients had undergone successful PTCA for dis- 
abling angina refractory to intensive pharmacologic 
treatment. They were selected on the basis of a normal 
exercise thallium scintigram and complete relief of 
chest pain 5 months after PTCA, when coronary angi- 
ography and left ventriculography were performed as 
part of an ongoing study on restenosis after PTCA. 
Informed consent was obtained for all investigations. 
Before PTCA, pharmacologic treatment consisted of 
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TABLE I Results of Coronary Flow Reserve and Quantitative Anglographic Data of PTCA Patients 
(mm21 
OA 
PTCA 
Before Afler 5 Months Follow-up 
Pt Age (yr) Sex Vessel OA DS CFR OA DS CFR OA DS CFR 
1 54 M LAD 1.2 53 1.0 
LC 3.9 
2 31 M LAD 0.5 70 1.0 
LC 3.3 
3 53 F LAD 0.5 72 0.6 
LC 2.6 
4 36 M LAD 0.4 70 1.2 
LC 3.2 
5 62 M LAD 0.6 66 1.0 
LC 2.6 
6 42 M LC 0.7 66 0.7 
LAD 3.6 
7 53 M R 1.3 65 0.9 
6 66 M LAD 0.7 56 1.4 
LC 3.5 
9 59 M LAD 1.1 64 1.0 
LC 3.2 
10 52 M LC 1.4 61 0.9 
LAD 3.9 
I1 64 M LAD 0.6 66 1.0 
LC 3.6 
12 53 M R 0.7 72 0.9 
13 47 M LAD 0.6 76 0.6 
LC 4.1 
I4 56 M R 0.6 71 1.4 
15 66 ‘M LAD 0.7 56 I.4 
LC 3.3 
5.4 14 
3.7 I5 
3.3 27 
3.7 14 
2.5 44 
3.6 24 
3.6 31 
2.9 26 
3.5 36 
3.0 32 
2.4 36 
3.2 49 
3.7 47 
2.9 40 
2.9 23 
3.0 
3.7 
2.3 
2.5 
2.8 
2.5 
3.3 
3.4 
2.1 
2.0 
1.5 
3.6 
2.2 
2.7 
3.0 
1.4 
3.5 
2.9 
4.0 
3.1 
3.3 
2.1 
1.8 
3.6 
2.0 
2.7 
3.5 
5.2 6 
3.1 19 
5.9 7 
2.8 20 
3.6 32 
2.6 38 
2.9 35 
3.1 12 
4.7 21 
3.9 28 
4.1 14 
3.5 39 
4.2 38 
3.6 31 
3.9 13 
2.9 
4.3 
2.5 
3.1 
3.7 
2.2 
2.9 
3.3 
3.8 
2.9 
3.4 
4.1 
3.9 
2.9 
3.4 
3.7 
3.5 
4.3 
3.7 
4.1 
4.6 
3.5 
3.9 
4.4 
3.0 
4.2 
3.6 
CFR = coronary flow reserve; DS = percentage diameter stenosis: LAD = left anterior descending artery: LC = 
circumflex artery; OA = mlnimal cross-sectional obstruction area (mm*); R = right coronary artery. 
p<o.o5 
D<0.001 - 
L 
I 3.8kO.9 
before after 5 months 
angioplasty follow up 
FIGURE 1. Results of quantltatlve analyses of coronary anglograms, 
before, lmmedlately after and 5 months afler percutaneous translu- 
mlnal coronary angloplasty. OA = mlnlmal cross-sectlonal obstruc- 
tlon area (mm*). 
nitrates, calcium antagonist agents and @blocking 
drugs, and during the 5 months after PTCA the pa- 
tients were treated with aspirin 500 mg/day and nifed- 
ipine 60 mg/day, which was continued on the day of 
cardiac catheterization. All 39 patients had normal sys- 
tolic and diastolic wall motion and an ejection fraction 
of 55%. Patients with left ventricular hypertrophy, val- 
vular heart disease, angiographic evidence of collater- 
al circulation, anemia, polycythemia or hypertension 
were excluded because these conditions may influ- 
ence coronary flow reserve.15-l7 
Exercise thallium scintigraphy: The patients per- 
formed a symptom-limited exercise test on the bicycle 
ergometer with stepwise increments of 20 watts/min. 
All patients exercised to more than 80% of their ex- 
pected normal exercise capacity (for age, sex and 
height). Images were obtained immediately after exer- 
cise and 4 hours later and analyzed prospectively by 3 
experienced observers without knowledge of the angi- 
ographic data. Redistribution and persistent defects 
were considered abnormal.lsJg 
Quantitative coronary cineangiography: Before 
PTCA, immediately after PTCA and during repeat 
catheterization, 2 or 3 identical angiographic projec- 
tions were filmed. The coronary arterial dimensions 
were determined with the computer-based Cardiovas- 
cular Angiography Analysis System.5*20J1 In essence, 
the boundaries of a selected coronary artery segment 
are detected automatically from optically magnified 
January 1. 1998 THE AMERICAN JOURNAL OF CARDIOLOGY Volume 61 57 
and video digitized regions of interest of a cineframe. 
Calibration of the diameter data in absolute values 
[millimeters) is achieved by detecting the boundaries 
of a section of the contrast catheter and comparing the 
mean diameter in pixels with the known size in milli- 
meters.22 Pincushion distortion is corrected.21 A com- 
puter estimation of the original arterial dimensions at 
the site of obstruction was used to define the reference 
region.21 The interpolated percentage diameter steno- 
sis and the minimal obstruction area (mm21 were then 
calculated by averaging the values from at least 2, 
preferably orthogonal, projections. A mean of 2.2 angi- 
ographic projections per patient was used in this study. 
Coronary flow reserve measurements: The heart 
was atrially paced at a rate just above the spontaneous 
heart rate. An electrocardiographic-triggered injection 
into the coronary artery 300 ms after the R wave was 
made with a fixed amount of Jopamidol at 37% 
through a Medrad Mark IV infusion pump. This non- 
ionic contrast agent has a viscosity of 9.4 CP at 37', an 
osmolality of 0.8 osm - kg-l and an iodine content of 
370 mg/ml. The injection rate of the contrast medium 
was judged to be adequate when back flow of contrast 
medium into the aorta occurred. In every patient the 
injection rate was identical for each coronary injec- 
tion. The field size of the x-ray equipment was 7 inch- 
es. The angiogram was repeated 30 seconds after phar- 
macologically induced hyperemia by a bolus injection 
of 12.5 mg papaverine into the coronary artery.5-23 Five 
end-diastolic cineframes were selected from succes- 
sive cardiac cycles. 
Logarithmic nonmagnified mask-mode back- 
ground subtraction was applied to the image subset to 
eliminate noncontrast medium densities. The last 
end-diastolic frame before contrast administration 
was chosen as the mask. A contrast appearance time 
was determined, using an empirically derived density 
threshold that was constant for each study and all pa- 
tients.5 A density image was computed, with each pixel 
intensity value being representative for the maximal 
local contrast medium accumulation. The coronary 
flow reserve was defined as the ratio of the regional 
flow computed from a hyperemic image (Qh] divided 
by the regional flow of the corresponding baseline 
image (Qb). Coronary flow reserve (CFR) was then be 
calculated as: 
Qh/Qb = Dh/Th : Db/Tb, 
where D is the mean contrast density and T the mean 
appearance time at baseline (b) and hyperemia (h). 
Appearance time and density were computed within 
user-defined regions of interest that were chosen in 
such a way that the epicardial coronary arteries visible 
on the angiogram, the coronary sinus and the great 
cardiac vein were excluded from the analysis.5 
Statistical analysis: Comparisons between groups 
were made after variance analysis with the Student t 
test for paired or unpaired observations. 
Results 
Quantitative cineangiography: The changes in 
minimal cross-sectional obstruction area are shown in 
Table I and Figure 1, and the changes in percentage 
diameter stenosis are shown in Table I and Figure 2. 
Percentage area stenosis (mean f standard deviation 
[SD]] decreased from 89 f 7 to 51 f 11% immediately 
after PTCA. Five months later, percentage area steno- 
sis was further decreased to 42 f 14% (p <0.05). 
Coronary flow reserve: In the 24 patients with an- 
giographically normal coronary arteries, coronary 
flow reserve ranged from 3.4 to 6.5 [Table II]. The 
mean value was 5.0 [SD f 0.8). The lower limit for a 
normal coronary flow reserve is therefore 3.4 (2 X SD 
below the mean coronary flow reserve). This is compa- 
rable to the normal values for coronary flow reserve 
reported by other groups .4s14 Coronary flow reserve 
was measured in the myocardial region supplied by 
the dilated coronary artery before PTCA, immediately 
after PTCA and 5 months later. Consecutive measure- 
ments were also obtained in 12 adjacent myocardial 
regions supplied by a nondilated coronary artery (Ta- 
ble I, Figure 3). The coronary flow reserve of these 
adjacent myocardial regions remained unchanged im- 
mediately after PTCA and after 5 months’ follow-up. 
Coronary flow reserve (mean f SD) in the myocardial 
region supplied by the dilated coronary artery in- 
creased from 1.0 f 0.3 to 2.5 f 0.6 immediately after 
PTCA (p <O.OOl). In none of these patients was coro- 
nary flow reserve restored to a normal level immedi- 
ately after PTCA. A substantial late improvement (p 
KO.01) in coronary flow reserve had occurred 5 months 
later. Coronary flow reserve in the myocardial region 
supplied by the dilated coronary artery 5 months after 
PTCA was of the same magnitude as the coronary flow 
reserve in the myocardial region supplied by a non- 
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FIGURE 2. Results of quantltatlve analyses of coronary anglograms, 
before, immediately after and 5 months after percutaneous translu- 
mlnal coronary angloplasty. DS = percentage diameter stenosis. 
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TABLE II Results of Coronary Flow Reserve ot Patients with 
Anglographically Normal Coronary Arteries 
Pt Age (~0 Sex Vessel CFR 
1 38 M LAD 8.5 
2 41 M LC 6.2 
3 62 F LAD 5.3 
4 31 M R 5.2 
5 60 M LC 5.0 
6 63 M LC 5.0 
7 54 M LC 5.0 
8 48 M LC 4.0 
9 66 F LC 4.5 
10 52 M LAD 4.0 
11 59 M LAD 5.0 
12 59 M LC 4.8 
13 47 M LC 4.9 
14 58 M LAD 3.7 
15 59 M LAD 4.3 
16 54 F LC 6.4 
17 61 M LAD 4.9 
18 62 M R 4.8 
19 58 M LAD 4.7 
20 57 M R 4.6 
21 64 M LAD 4.5 
22 61 M LAD 3.4 
23 50 M LAD 6.3 
24 58 M LAD 4.0 
CFR = coronary flow reserve; LAD = left anterior descending coronary 
artery; LC = circumflex artery: R = right coronary artery. 
CFR 
dilated and angiographically not diseased coronary ar- 
tery. In 11 of the 15 patients (73%) coronary flow re- 
serve of the dilated coronary artery was restored to a 
normal level of 23.4, whereas in 4 of 15 patients (27%) 
coronary flow reserve was still abnormal (Figures 4 
and 5). Coronary flow reserve 5 months after PTCA 
was related to the change in minimal cross-sectional 
obstruction area occurring between immediately after 
PTCA and at follow-up (linear regression analysis: r = 
0.61, standard error of the estimate = 0.46, Figure 6). In 
10 patients the minimal cross-sectional obstruction 
area 5 months after PTCA was larger than immediate- 
ly after the procedure [late improvement), Only 1 pa- 
tient had a coronary flow reserve of <3.4. In 5 patients 
the minimal cross-sectional obstruction area 5 months 
after PTCA was smaller than the area immediately 
after the procedure [late deterioration). The percent- 
age of patients showing normalization of coronary 
flow reserve 5 months after PTCA is substantially 
higher (p <O.O5, chi-square test) in the group with late 
angiographic improvement (9070) compared with the 
group with late deterioration (40%). 
Discussion 
The purpose of the present study was to establish 
whether coronary flow reserve in a myocardial region 
5 p<o. 041 
p<o. 01 p=NS 
I 7 I 1 
FIGURE 3. Coronary flow reserve (CFR) mea- 
sured wlth dlgltal subtractlon clneanglography, 
before, lmmedlately after and 5 months after 
percutaneous translumlnal coronary anglo- 
plesty. The shaded bars represent the CFR of 
the myocardlel region supplled by the dilated 
coronary artery. The open bars represent the 
CFR of an adjacent myocardlal region wpplled 
by a nondllated and anglographlcally normal 
coronary artery. 
L 
before after 5 months 
angioplasty follow up 
CFR 
FIGURE 4. Coronary flow reserve (CFR) plotted 
against mlnlmal cross-sectlonal obstructlon area 
(OA) 5 months after percutaneous translumlnal 
coronary angloplasty. The lower llmlt of the normal 
value for CFR as measured with the dlgltal sub- 
tractlon clneanglographlc technique Is 3.4. 
1 2 3 4 5 6 
OA (mm21 
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supplied by a stenotic coronary artery could be re- 
stored to normal by PTCA. Immediately after PTCA, 
coronary flow reserve is not normalized.*l-l4 In 11 of 
our 15 patients without angina and with normal exer- 
cise thallium scintigraphy 5 months after PTCA, coro- 
nary flow reserve was normalized. There are several 
possible explanations for this phenomenon. 
First, since coronary flow reserve is a ratio between 
maximal coronary blood flow and resting flow, an in- 
crease in resting flow results in a decrease of this ratio. 
The radiographic technique we used does not provide 
us with absolute measurements of volume flow and we 
therefore cannot draw any conclusion regarding the 
resting coronary volume flow after the PTCA proce- 
dure. However, several investigators using the ther- 
modilution technique in the coronary sinus or the great 
cardiac vein have reported comparable resting volume 
flows before and after PTCA.24-26 
Second, metabolic, humoral or myogenic factors 
may limit coronary flow reserve after PTCA. The met- 
abolic derangements due to the PTCA seem quickly 
reversible, as shown by the fast decline of temporarily 
increased lactate, hypoxanthine and potassium ion 
concentrations,24T27 andare therefore not likely to be of 
major significance. Although humoral factors such as 
thromboxane releasez8 may influence vasoactive regu- 
lation in a specific subgroup of patients with compli- 
cated PTCA, so far no evidence has been presented for 
the persistence of humoral derangements after PTCA. 
The long-standing reduction in perfusion pressure dis- 
tal to the stenotic lesion may induce alterations in the 
complex mechanism of coronary blood flow autoregu- 
lation,ll and a prolonged period of time might be need- 
ed before these abnormalities subside.29 
Third, the impaired coronary flow reserve could be 
directly related to the severity of the residual stenosis. 
Cross-sectional area as measured immediately after 
PTCA, generally, is about threefold increased as a re- 
sult of the procedure, but it remains grossly abnor- 
ma1.30p31 In the 6 months after PTCA important mor- 
phologic changes may take place. Johnson et a130 
CFR 
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FIGURE 5. Coronary flow reserve (CFR) plotted against percentage 
diameter stenosis (DS) 5 months after percutaneous translumlnal 
coronary angloplasty. The lower limit of the normal value for CFR as 
measured wlth the dlgltal subtraction clneanglographlc technique Is 
3.4. 
reported a late increase in cross-sectional obstruction 
area in about one-third of their patients. In our select- 
ed group of patients with no angina and a normal 
exercise thallium scintigram, the percentage of pa- 
tients with late angiographic improvement was even 
higher (66%). In a previous study in our laboratory the 
relation between cross-sectional obstruction area and 
coronary flow reserve in patients with stable angina 
CFR 
5 
4 
3. 
3 0 0 0 
0 
2 
CFR=O. 29AOA+3.4 
1 r=0.61 SEE=O. 54 
OJ I I I I I 
-1 0 1 2 3 
AOA (mm2) 
FIGURE 6. Relation between coronary flow reserve (CFR) 5 months 
atter percutaneous translumlnal angloplasty and the change that 
occurred in mlnlmal cross-sectional obstruction area (AOA) be- 
tween Immediately after percutaneous translumlnal coronary angl- 
oplasty and 5 months later. The lower llmlt of the normal value for 
CFR as measured with the digital subtraction clneanglographlc 
technique Is 3.4. 
CFR 
OJ , / I I ! 1 
0 1 2 3 4 
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FIGURE 7. Relation between coronary flow reserve (CFR) and 
cross-sectional obstructlon area (OA) as prevlously reported.5 The 
solid line Is the best fit curve and the shaded area corresponds to 
the g5% confidence llmlts. The mean values and standard devl- 
ations of coronary flow reserve and obstructlon area as obtalned In 
the present study, before percutaneous translumlnal coronary angl- 
oplasty (cfrcfe), lmmedlately after (square) and 5 months later 
(frlangfe), are plotted on thls diagram. 
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and single-vessel coronary artery disease has been es- 
tablished.5 In Figure 7 this relation is shown with the 
results of the sequential coronary flow reserve and 
obstruction area measurements of the present study 
superimposed. The data of the present study are with- 
in the 95% confidence limits of the relation between 
flow reserve and obstruction area. Therefore, the per- 
sisting reduced obstruction area is by itself a sufficient 
explanation for the limited restoration of coronary 
flow reserve, although it does not rule out other con- 
tributing pathophysiologic mechanisms, 
Limitations: There are 2 important limitations of 
coronary angiography in the setting of PTCA. First, the 
changes in luminal size of an artery after the mechani- 
cal disruption of its internal wall may be difficult to 
assess by angiographic means.31,32 The irregular shape 
with intimal tears that fill with contrast medium to a 
variable extent will result in some overestimation of 
the true functional luminal size immediately after 
PTCA. Second, the extent of coronary atherosclero- 
sis may be difficult to delineate angiographically. 
McPherson et a133 documented that substantial intimal 
atherosclerosis resulting in diffuse obstructive disease 
that involves the entire length of an epicardial artery is 
often present, even when angiograms reveal only dis- 
crete lesions. As a consequence, relative measure- 
ments of stenosis everity are an inadequate approach 
to assessing the severity of coronary obstructions. This 
may explain why 4 of our patients with only very mild 
residual stenoses 5 months after PTCA still had an 
abnormal vasodilatory reserve. 
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